Per Munck Af Rosenschöld (Per Munck Af Rosenschold)

Scopus Author ID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Prostate Cancer

Cognitive Impairment

Radiation Therapy

Hyaluronic Acid

Top Venues

Science advances

Acta oncologica (Stockholm, Sweden)

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence

Radiation oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Gram, N Patrik Brodin, Thomas Björk-Eriksson, Karsten Nysom, Per Munck Af Rosenschöld
The risk of radiation-induced neurocognitive impairment and the impact of sparing the hippocampus during pediatric proton cranial irradiation. Acta oncologica (Stockholm, Sweden) (2023)
Ingrid Tonning Olsson, Johan Lundgren, Lars Hjorth, Per Munck Af Rosenschöld, Åsa Hammar, Sean Perrin
Neurocognitive development after pediatric brain tumor - a longitudinal, retrospective cohort study. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence (2023)
Albert Juan Fuglsang-Madsen, Jonas R Henriksen, Rasmus I Jølck, Frederikke P Fliedner, Linda M Bruun, Jonas Scherman, Andreas I Jensen, Per Munck Af Rosenschöld, Lilah Moorman, Sorel Kurbegovic, Steen R de Blanck, Klaus R Larsen, Paul F Clementsen, Anders N Christensen, Mads Hartvig Clausen, Wenbo Wang, Paul Joseph Kempen, Merete Christensen, Niels-Erik Viby, Gitte Fredberg Persson, Rasmus Larsen, Knut Conradsen, Fintan J McEvoy, Andreas Kjaer, Thomas Eriksen, Thomas Lars Andresen
Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention. Science advances 6 (34) (2020)
Per Munck Af Rosenschöld, Michael J Zelefsky, Aditya P Apte, Andrew Jackson, Jung Hun Oh, Elliot Shulman, Neil Desai, Margie Hunt, Pirus Ghadjar, Ellen Yorke, Joseph O Deasy
Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control. Radiation oncology (London, England) 13 (1) (2018)